Meet-URO 13

Efficacy of Immunotherapy blockade despite the Early Treatment interruption due to serious immune-related adverse events. (The EvIdEnT trial)

Stato

Studio chiuso

Patologia

Rene

Tipologia

Retrospettivo, Osservazionale

Centro Coordinatore: Policlinico Universitario Campus Bio Medico - Roma
Principal Investigator: Daniele Santini
Sub Investigator: -
Study Coordinator: -

Documentazione disponibile